Mir Hashim
2022
In 2022, Mir Hashim earned a total compensation of $2.3M as Chief Scientific Officer at Rani Therapeutics Holdings, a 54% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $249,600 |
|---|---|
| Option Awards | $1,114,129 |
| Salary | $412,000 |
| Stock Awards | $544,252 |
| Total | $2,319,981 |
Hashim received $1.1M in option awards, accounting for 48% of the total pay in 2022.
Hashim also received $249.6K in non-equity incentive plan, $412K in salary and $544.3K in stock awards.
Rankings
In 2022, Mir Hashim's compensation ranked 1,553rd out of 5,753 executives tracked by ExecPay. In other words, Hashim earned more than 73.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,553 out of 5,753 | 73rd |
Division Manufacturing | 791 out of 3,133 | 75th |
Major group Chemicals And Allied Products | 310 out of 1,419 | 78th |
Industry group Drugs | 288 out of 1,320 | 78th |
Industry Pharmaceutical Preparations | 204 out of 966 | 79th |
Source: SEC filing on April 11, 2023.
Hashim's colleagues
We found two more compensation records of executives who worked with Mir Hashim at Rani Therapeutics Holdings in 2022.